Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation

Retrieved on: 2024-03-25 18:02:59

Tags for this article:

Click the tags to see associated articles and topics

Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation. View article details on hiswai:

Excerpt

BEDMINSTER, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical ...

Article found on: www.globenewswire.com